11,486 research outputs found
Optimality of Graphlet Screening in High Dimensional Variable Selection
Consider a linear regression model where the design matrix X has n rows and p
columns. We assume (a) p is much large than n, (b) the coefficient vector beta
is sparse in the sense that only a small fraction of its coordinates is
nonzero, and (c) the Gram matrix G = X'X is sparse in the sense that each row
has relatively few large coordinates (diagonals of G are normalized to 1).
The sparsity in G naturally induces the sparsity of the so-called graph of
strong dependence (GOSD). We find an interesting interplay between the signal
sparsity and the graph sparsity, which ensures that in a broad context, the set
of true signals decompose into many different small-size components of GOSD,
where different components are disconnected.
We propose Graphlet Screening (GS) as a new approach to variable selection,
which is a two-stage Screen and Clean method. The key methodological innovation
of GS is to use GOSD to guide both the screening and cleaning. Compared to
m-variate brute-forth screening that has a computational cost of p^m, the GS
only has a computational cost of p (up to some multi-log(p) factors) in
screening.
We measure the performance of any variable selection procedure by the minimax
Hamming distance. We show that in a very broad class of situations, GS achieves
the optimal rate of convergence in terms of the Hamming distance. Somewhat
surprisingly, the well-known procedures subset selection and the lasso are rate
non-optimal, even in very simple settings and even when their tuning parameters
are ideally set
Functional renormalization group study of the Quark-Meson model with meson
We study the phase diagram of two-flavor massless QCD at finite baryon
density by applying the functional renormalization group (FRG) for a
quark-meson model with , and mesons. The dynamical
fluctuations of quarks, , and are included into the flow
equations, while the amplitudes of -fields are also allowed to
fluctuate. At high temperature the effects of the -field on the phase
boundary are qualitatively similar to the mean-field calculations; the phase
boundary is shifted to the higher chemical potential region. As the temperature
is lowered, however, the transition line bends back to the lower chemical
potential region, irrespective to the strength of the vector coupling. In our
FRG calculations, the driving force of the low temperature first order line is
the fluctuations rather the quark density, and the effects of -fields
have little impact. At low temperature, the effective potential at small
field is very sensitive to the infrared cutoff scale, and this
significantly affects our determination of the phase boundaries. The critical
chemical potential at the tricritical point is affected by the -field
effects but its critical temperature stays around the similar value. Some
caveats are given in interpreting our model results.Comment: 10 pages, 11 figure
Lasso adjustments of treatment effect estimates in randomized experiments
We provide a principled way for investigators to analyze randomized
experiments when the number of covariates is large. Investigators often use
linear multivariate regression to analyze randomized experiments instead of
simply reporting the difference of means between treatment and control groups.
Their aim is to reduce the variance of the estimated treatment effect by
adjusting for covariates. If there are a large number of covariates relative to
the number of observations, regression may perform poorly because of
overfitting. In such cases, the Lasso may be helpful. We study the resulting
Lasso-based treatment effect estimator under the Neyman-Rubin model of
randomized experiments. We present theoretical conditions that guarantee that
the estimator is more efficient than the simple difference-of-means estimator,
and we provide a conservative estimator of the asymptotic variance, which can
yield tighter confidence intervals than the difference-of-means estimator.
Simulation and data examples show that Lasso-based adjustment can be
advantageous even when the number of covariates is less than the number of
observations. Specifically, a variant using Lasso for selection and OLS for
estimation performs particularly well, and it chooses a smoothing parameter
based on combined performance of Lasso and OLS
Iterative detection and decoding for SCMA systems with LDPC codes
Sparse code multiple access (SCMA) is a promising multiplexing approach to
achieve high system capacity. In this paper, we develop a novel iterative
detection and decoding scheme for SCMA systems combined with Low-density
Parity-check (LDPC) decoding. In particular, we decompose the output of the
message passing algorithm (MPA) based SCMA multiuser detection into intrinsic
part and prior part. Then we design a joint detection and decoding scheme which
iteratively exchanges the intrinsic information between the detector and the
decoder, yielding a satisfied performance gain. Moreover, the proposed scheme
has almost the same complexity compared to the traditional receiver for
LDPC-coded SCMA systems. As numerical results demonstrate, the proposed scheme
has a substantial gain over the traditional SCMA receiver on AWGN channels and
Rayleigh fading channels
Enhanced optical Kerr nonlinearity of graphene/Si hybrid waveguide
In this work, we experimentally study the optical kerr nonlinearities of
graphene/Si hybrid waveguides with enhanced self-phase modulation. In the case
of CMOS compatible materials for nonlinear optical signal processing, Si and
silicon nitride waveguides have been extensively investigated over the past
decade. However, Si waveguides exhibit strong two-photon absorption (TPA) at
telecommunication wavelengths, which lead to a significant reduction of
nonlinear figure of merit. In contrast, silicon nitride based material system
usually suppress the TPA, but simultaneously leads to the reduction of the Kerr
nonlinearity by two orders of magnitude. Here, we introduce a graphene/Si
hybrid waveguide, which remain the optical properties and CMOS compatibility of
Si waveguides, while enhance the Kerr nonlinearity by transferring patterned
graphene over the top of the waveguides. The graphene/Si waveguides are
measured with a nonlinear parameter of 510 W-1m-1. Enhanced nonlinear
figure-of-merit (FOM) of 2.48 has been achieved, which is three times higher
than that of the Si waveguide. This work reveals the potential application of
graphene/Si hybrid photonic waveguides with high Kerr nonlinearity and FOM for
nonlinear all-optical signal processing.Comment: 11pages, 6 figures, journal articl
Anomalous gauge couplings of the Higgs boson at the CERN LHC: Semileptonic mode in WW scatterings
We make a full tree level study of the signatures of anomalous gauge
couplings of the Higgs boson at the CERN LHC via the semileptonic decay mode in
WW scatterings. Both signals and backgrounds are studied at the hadron level
for the Higgs mass in the range 115 GeV to 200 GeV. We carefully impose
suitable kinematical cuts for suppressing the backgrounds. To the same
sensitivity as in the pure leptonic mode, our result shows that the
semileptonic mode can reduce the required integrated luminosity by a factor of
3. If the anomalous couplings in nature are actually larger than the
sensitivity bounds shown in the text, the experiment can start the test for an
integrated luminosity of 50 inverse fb.Comment: PACS numbers updated. Version published in Phys.Rev.D79,055010(2009
Traffic-Aware Transmission Mode Selection in D2D-enabled Cellular Networks with Token System
We consider a D2D-enabled cellular network where user equipments (UEs) owned
by rational users are incentivized to form D2D pairs using tokens. They
exchange tokens electronically to "buy" and "sell" D2D services. Meanwhile the
devices have the ability to choose the transmission mode, i.e. receiving data
via cellular links or D2D links. Thus taking the different benefits brought by
diverse traffic types as a prior, the UEs can utilize their tokens more
efficiently via transmission mode selection. In this paper, the optimal
transmission mode selection strategy as well as token collection policy are
investigated to maximize the long-term utility in the dynamic network
environment. The optimal policy is proved to be a threshold strategy, and the
thresholds have a monotonicity property. Numerical simulations verify our
observations and the gain from transmission mode selection is observed.Comment: 7 pages, 6 figures. A shorter version is submitted to EUSIPC
A Novel Aptamer LL4A Specifically Targets Vemurafenib-Resistant Melanoma through Binding to the CD63 Protein.
Melanoma is a highly aggressive tumor with a poor prognosis, and half of all melanoma patients harbor BRAF mutations. A BRAF inhibitor, vemurafenib (PLX4032), has been approved by the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) to treat advanced melanoma patients with BRAFV600E mutation. However, the efficacy of vemurafenib is impeded by adaptive resistance in almost all patients. In this study, using a cell-based SELEX (systematic evolution of ligands by exponential enrichment) strategy, we obtained a DNA aptamer (named LL4) with high affinity and specificity against vemurafenib-resistant melanoma cells. Optimized truncated form (LL4A) specifically binds to vemurafenib-resistant melanoma cells with dissociation constants in the nanomolar range and with excellent stability and low toxicity. Meanwhile, fluorescence imaging confirmed that LL4A significantly accumulated in tumors formed by vemurafenib-resistant melanoma cells, but not in control tumors formed by their corresponding parental cells in vivo. Further, a transmembrane protein CD63 was identified as the binding target of aptamer LL4A using a pull-down assay combined with the liquid chromatography-tandem mass spectrometry (LC-MS/MS) method. CD63 formed a supramolecular complex with TIMP1 and β1-integrin, activated the nuclear factor кB (NF-кB) and mitogen-activated protein kinase (MAPK) signaling pathways, and contributed to vemurafenib resistance. Potentially, the aptamer LL4A may be used diagnostically and therapeutically in humans to treat targeted vemurafenib-resistant melanoma
- …
